Crossmark

Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicity

Published Online: 2022-05-28

Published Print: 2022-08

Authors

Bartalena, L. https://orcid.org/0000-0001-8447-5449
Marcocci, C.

Tanda, M. L.

Marinò, M.
License Information

Text and Data Mining valid from 2022-05-28

Version of Record valid from 2022-05-28
More Information

Article History

Received: 20 May 2022

Accepted: 24 May 2022

First Online: 28 May 2022

Declarations

:

: The authors have no conflict of interest to declare. LB is the Editor-in-Chief, and MM and MLT are members of the Editorial Board of the Journal of Endocrinological Investigation.

: No approval from the Institutional Ethics Committee was needed.

: The article did not involve humans; therefore, no informed content was needed.

Document is current